Surface expression of only gamma delta and/or alpha beta T cell receptor heterodimers by cells with four (alpha, beta, gamma, delta) functional receptor chains. promising immunotherapy strategy for cancer. Chimeric antigen receptor (CAR)-modified T cells have shown promise in the treatment of B cell malignancy. (1) However, ACT immunotherapy for solid tumors faces the challenge … Continue reading Surface expression of only gamma delta and/or alpha beta T cell receptor heterodimers by cells with four (alpha, beta, gamma, delta) functional receptor chains